NYC Hep B Coalition
NYC Hep C Task Force

Connect on LinkedIn

Subscribe to Posts


 

Subscribe to Posts


 

NYC Hep B & C Personal Stories Workshop

The life stories of people who have personally experienced Hepatitis B & C are extraordinary.

A small group meets monthly in mid-town Manhattan to share our personal stories, and work on ways to develop them so that they can help the world better understand the reality of living with Hepatitis, as well as prevention, management & care.

Please Contact Us if you have a story to tell! You can share your story from afar, or you can join our group.

We are looking for writers, artists, video, photographers, producers and dissemination opportunities to support the goals of the group! If you are in the position to help support the group development or contribute artistically or technically, please also contact us.

See some of the stories on our page: Living with Hep B or Living with Hep C.

Resources

More News Posts

Global Access to Gilead Hep B Meds

August 19, 2014

List of countries where individuals can access Gilead medication for HBV; this is in response for those who are on medication and traveling abroad for 3 months or longer.​ ———————————- ASIA Approved: Bangladesh, Bhutan, Cambodia, China, Taiwan, Hong Kong, India, Iran, Israel,  Kazakhstan, Kyrgyzstan, Laos, Myanmar, Pakistan, Saudi Arabia, Singapore, South Korea, Syria, Taiwan, Thailand, Timor, UAE, … Continue reading Global Access to Gilead Hep B Meds

read more »

New! Hep C CHI: NYC Health Dept Publication for Medical Providers

August 4, 2014

New! NYC Department of Health City Health Information (CHI) on Hep C 2014   The Diagnosing and Managing Hepatitis C CHI provides a thorough summary of risk assessment, testing recommendations, laboratory tests, and managing current HCV infection. There is specific information on how providers should speak to patients currently infected with HCV, as well as tables detailing common HCV … Continue reading New! Hep C CHI: NYC Health Dept Publication for Medical Providers

read more »

Olysio-Sovaldi Combo Becomes 2nd FDA-approved All-oral HCV Treatment

November 19, 2014

Olysio has been approved by the FDA, in combination with Sovaldi, for the treatment of Hepatitis C. It is substantially more expensive than Harvoni; although it depends on treatment time, a 12-week Harvoni treatment costs $94,500, compared to the Olysio-Sovaldi 12-week tag of $150,360. Olysio in combination with Sovaldi is the second Hepatitis C combination treatment regimen … Continue reading Olysio-Sovaldi Combo Becomes 2nd FDA-approved All-oral HCV Treatment

read more »

HIV/Hepatitis C (HCV) Co‐infection among Men who have Sex with Men (MSM) in New York City (NYC), 2000‐2010. Poster ID Week 2013 Conference

October 9, 2013

HIV/Hepatitis C (HCV) Co‐infection among Men who have Sex with Men (MSM) in New York City (NYC), 2000‐2010. Ann Drobnik, MPH, Jessie Pinchoff, PhD Candidate, MPH, Jennifer Fuld, PhD Candidate, MA, Katherine Bornschlegel, Jay K. Varma, MD, Sarah L. Braunstein, PhD. Division of Disease Control, New York City Department of Health and Mental Hygiene (NYC … Continue reading HIV/Hepatitis C (HCV) Co‐infection among Men who have Sex with Men (MSM) in New York City (NYC), 2000‐2010. Poster ID Week 2013 Conference

read more »

Webinar | Navigating Hep C: What Patients Need to Know

March 6, 2015

NVHR Webinar: Navigating Hepatitis C: What Patients Need to Know Please register for our upcoming webinar: Navigating Hepatitis C: What Patients Need to Know. This webinar, which will be held on March 18, 2015, at 2 pm Eastern, will cover the most important elements that patients need to know regarding screening, access to care, receiving … Continue reading Webinar | Navigating Hep C: What Patients Need to Know

read more »

New! 2013 NYC Hep B & C Surveillance Report (NYC Health Dept, 2015)

February 26, 2015

2013 NYC Hepatitis B & C Surveillance Report NYC Health Department, February 2015. To view click here See also NYC Health Department Online Data Portal EpiQuery. Click here                    

read more »